In conclusion, patients with T2D showed elevated levels of PPBP, THBS1, and CDH1, circulatory proteins that have been suggested to be biomarkers of AIS due to LVO, and therefore may identify a cohort of T2D patients at increased risk of AIS. The gene discussed is CDH1; the disease is androgen insensitivity syndrome.